As India rolled out booster shots for health workers, frontline workers and senior citizens at risk, the Indian Council of Medical Research has said that the third dose of Covaxin holds promise
The medical research body on Sunday tweeted the benefits of getting Covaxin's precautionary dose. It said, "Reassuring information on safety and immunogenicity of a booster dose of Covaxin administered six months after completion of a two dose primary vaccination series with Covaxin."
The government has said that the third dose will be of the same vaccine as the first two and there will be no mix and match.
The government has started administering 'precaution' doses of Covid-19 vaccines to frontline workers, healthcare workers and senior citizens with co-morbidities.
On December 25, Prime Minister Narendra Modi had announced that from January 3, 2022 vaccination will start for the children in the age group of 15-18 years and further announced administration of precaution dose for healthcare and frontline workers from January 10, 2022.
Also Watch| Covid-19: India rolls out booster dose for health workers, at-risk elders amid Omicron wave